300 mg<unk>  with 100 mg<unk> , twice daily for 5 days
Treatment of high risk patients with mild-to-moderate disease
Initiate within 5 days of symptom onset
Treatment of high risk patients with mild-to-moderate disease
Initiate within 5 days of symptom onset
Ritonavir-boosted nirmatrelvir
Abacavir/lamivudine
Baloxavir marboxil
Emtricitabine/tenofovir
HIV post-exposure prophylaxis
Ribavirin
Lopinavir
Raltegravir